Location History:
- Edmonton, CA (1997 - 1999)
- London, CA (2009 - 2011)
Company Filing History:
4 out of 15 
1 out of 366 
Years Active: 1997-2011
Title: D Grant McFadden: Innovator in Transplant Rejection Treatments
Introduction
D Grant McFadden is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of medicine, particularly in the area of transplant rejection treatments. With a total of five patents to his name, McFadden's work has the potential to improve the lives of many patients undergoing transplant procedures.
Latest Patents
Among his latest patents, McFadden has developed methods for treating transplant rejection. These compositions and methods involve administering a therapeutically effective amount of Serp-1, its analogs, and biologically active fragments in combination with an anti-rejection agent, such as cyclosporin. This innovative approach aims to treat both acute and chronic allograft and xenograft transplant rejection in mammals.
Career Highlights
Throughout his career, McFadden has worked with various organizations, including Viron Therapeutics, Inc. and Research Corporation Technologies, Inc. His expertise in the field has allowed him to make substantial advancements in medical treatments related to transplant procedures.
Collaborations
Some of McFadden's notable coworkers include Alexandra Lucas and Robert Zhong. Their collaborative efforts have contributed to the success of his innovative projects.
Conclusion
D Grant McFadden's work in developing methods for treating transplant rejection showcases his dedication to improving medical treatments. His patents reflect a commitment to advancing healthcare and enhancing the quality of life for transplant recipients.